Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
334,602
-
Shares change
-
+113,650
-
Total reported value, excl. options
-
$1,258,504
-
Value change
-
+$384,351
-
Number of buys
-
10
-
Number of sells
-
2
-
Price
-
$3.77
Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q3 2025
As of 30 Sep 2025 ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 334,602 shares of stock of the company.
Largest 10 holders included Twin Lakes Capital Management, LLC, MORGAN STANLEY, HB Wealth Management, LLC, GREENLEAF TRUST, CITADEL ADVISORS LLC, BNP PARIBAS FINANCIAL MARKETS, ACADIAN ASSET MANAGEMENT LLC, RHUMBLINE ADVISERS, CITIGROUP INC, and OSAIC HOLDINGS, INC..
This table shows 16 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.